BNTX Fair Price
$42.68
Overvalued by 89.9%
To display the fair price of a share, you need to be a member of Bulios Black.
My Notes
Začít psátFeed
Read More
Today, BioNTech $BNTX reported quarterly results, which currently focuses on, for example, the development and research of drugs aimed at treating cancer and infectious diseases. Q2 2023 earnings were in the red, with the company reporting a loss of -190.4 million, compared to a profit of 1.7 billion in Q2 2022. The company has invested heavily in R&D this year, so hopefully...
Read more
Zobrazit další komentáře
Healthcare is not represented at all... I honestly don't even know what to look for in it, I don't know any companies and I don't even have anyone around to ask in that regard :) It's a bit of a blackbox for me.
Read More
BioNTech $BNTX
BioNTech reported its results yesterday.
This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.
It is also known for the development and production of the COVID-19 vaccine with Pfizer.
Results for the first quarter of this year :
Revenues : EUR 1.28 billion, first...
Read more
Zobrazit další komentáře
As has been written here, the drop in sales is really big, but it's probably really just because of the covid.